Education
About Us
Working with TipRanks
Follow Us
Magle Chemoswed Holding AB (SE:MAGLE)
:MAGLE
MAGLE Stock Chart & Stats
kr18.10
-kr1.20(-3.66%)
At close: 4:00 PM EST
kr18.10
-kr1.20(-3.66%)
Day’s Range― - ―
52-Week Rangekr17.10 - kr38.00
Previous CloseN/A
Volume1.20K
Average Volume (3M)1.06K
Market Cap
€394.40M
Enterprise Valuekr877.36M
Total Cash (Recent Filing)€2.15M
Total Debt (Recent Filing)€342.63M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Feb 27, 2026EPS EstimateN/A
Last Dividend Ex-Date
Apr 26, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding20,649,378
10 Day Avg. Volume1,291
30 Day Avg. Volume1,058
Financial Highlights & Ratios
PEG Ratio-2.10
Price to Book (P/B)0.79
Price to Sales (P/S)1.88
P/FCF Ratio-15.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Magle Chemoswed Holding AB News
MAGLE FAQ
What was Magle Chemoswed Holding AB’s price range in the past 12 months?
Magle Chemoswed Holding AB lowest stock price was kr17.10 and its highest was kr38.00 in the past 12 months.
What is Magle Chemoswed Holding AB’s market cap?
Magle Chemoswed Holding AB’s market cap is €394.40M.
When is Magle Chemoswed Holding AB’s upcoming earnings report date?
Magle Chemoswed Holding AB’s upcoming earnings report date is Feb 27, 2026 which is in 93 days.
How were Magle Chemoswed Holding AB’s earnings last quarter?
Magle Chemoswed Holding AB released its earnings results on Oct 31, 2025. The company reported kr0.152 earnings per share for the quarter, missing the consensus estimate of kr0.2 by -kr0.048.
Is Magle Chemoswed Holding AB overvalued?
According to Wall Street analysts Magle Chemoswed Holding AB’s price is currently Overvalued.
Does Magle Chemoswed Holding AB pay dividends?
Magle Chemoswed Holding AB pays a Notavailable dividend of kr0.35 which represents an annual dividend yield of N/A. See more information on Magle Chemoswed Holding AB dividends here
What is Magle Chemoswed Holding AB’s EPS estimate?
Magle Chemoswed Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Magle Chemoswed Holding AB have?
Magle Chemoswed Holding AB has 20,649,378 shares outstanding.
What happened to Magle Chemoswed Holding AB’s price movement after its last earnings report?
Magle Chemoswed Holding AB reported an EPS of kr0.152 in its last earnings report, missing expectations of kr0.2. Following the earnings report the stock price went down -6.863%.
Which hedge fund is a major shareholder of Magle Chemoswed Holding AB?
Currently, no hedge funds are holding shares in SE:MAGLE
Company Description
Magle Chemoswed Holding AB
Magle Chemoswed Holding AB (MAGLE) is a prominent player in the pharmaceutical and biotechnology sectors, specializing in drug development and manufacturing services. The company focuses on advanced drug delivery systems, including liposomal formulations and other innovative technologies aimed at enhancing the therapeutic efficacy and safety of pharmaceutical products. MAGLE operates with a commitment to providing high-quality services to both emerging biotech firms and established pharmaceutical companies, helping them to bring their products to market efficiently.
Technical Analysis
Xbrane Biopharma AB
―
Intervacc AB
―
Guard Therapeutics International AB
―
Immunicum AB
―
Corline Biomedical AB
―